According to the announcement from Shanghai Kaibao (300039.SZ), the company has received a decision from the Shanghai Securities Regulatory Bureau of the China Securities Regulatory Commission (referred to as "Shanghai Securities Regulatory Bureau") regarding the implementation of corrective measures against Shanghai Kaibao Pharmaceutical Co., Ltd. and the issuance of warning letters to Mu Jingwei, Zhou Yingbin, Ren Liwang, and Chen Youlong.

It is reported that the company has issues such as using employees' personal bank cards for secondary salary distribution, using employees' personal bank cards to collect social security payments, irregularities in labor fee disbursement, and discrepancies between sales expense accounting and actual expenses incurred. Mu Jingwei, as the chairman of the company, Zhou Yingbin, as a director and general manager, Ren Liwang, as a director and then financial director and board secretary, and Chen Youlong, as the current financial director, are responsible for the company's aforementioned violations